

Niger has stopped mass drug administration (MDA) for lymphatic filariasis in 80% of endemic districts in the country following interruption of transmission of the causative parasite in 43 districts. Prevalence of infection has been reduced significantly in the remaining 11 districts due to annual MDA.

89% of trachoma endemic districts have stopped MDA in all evaluation units after trachoma impact surveys indicated the elimination threshold of trachomatous inflammation—follicular (TF) of less than 5% among children ages 1-9 years FY21 (October 2020 - September 2021).

The national onchocerciasis elimination committee of Niger has determined that the country has successfully eliminated transmission following entomological and epidemiological surveys. The country is developing a dossier to be submitted for verification to the World Health Organization. The country is poised to become the first country to eliminate onchocerciasis in Africa.
Standard Disease-Specific Indicators as of FY20
FY20 is October 2019 through September 2020

of ever-endemic districts have stopped MDA as of FY20
(i.e. have passed stop MDA survey, TAS1 (First Transmission Assessment Survey))
No ever-endemic districts in post-surveillance phase as of FY20
(i.e. have passed last surveillance survey, TAS3 (third Transmission Assessment Survey))
of persons no longer at risk as of FY20 among those who were ever at risk

of ever-endemic districts have stopped MDA as of FY20
(i.e. have passed stop MDA survey, TIS (Trachoma Impact Survey))
of ever-endemic districts in post-surveillance phase as of FY20
(i.e. have passed surveillance survey, TSS (Trachoma Surveillance Survey))
of persons no longer at risk as of FY20 among those who were ever at risk
Niger’s government has announced elimination of OV although dossier not yet submitted to WHO.

of ever endemic districts have been treated at least once as of FY20§§
§§ SCH is not supported by USAID
